Aphria (APHA) Trading Up 0.3%

Share on StockTwits

Aphria Inc (NYSE:APHA) was up 0.3% on Monday . The company traded as high as $7.20 and last traded at $6.94. Approximately 159,522 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 7,550,646 shares. The stock had previously closed at $6.92.

A number of equities research analysts have recently weighed in on APHA shares. Canaccord Genuity reiterated a “buy” rating on shares of Aphria in a research report on Wednesday, December 5th. Eight Capital downgraded shares of Aphria to a “hold” rating and set a $7.00 price target for the company. in a research report on Thursday, December 13th.

Aphria (NYSE:APHA) last announced its quarterly earnings data on Friday, October 12th. The company reported $0.07 EPS for the quarter. The firm had revenue of $10.15 million for the quarter.

ILLEGAL ACTIVITY WARNING: “Aphria (APHA) Trading Up 0.3%” was first reported by Zolmax and is the sole property of of Zolmax. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://zolmax.com/investing/aphria-apha-trading-up-0-3/2824446.html.

Aphria Company Profile (NYSE:APHA)

Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.

Featured Story: How is Preferred Stock Different from Common Stock?

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Digital Turbine  Stock Rating Upgraded by Zacks Investment Research
Digital Turbine Stock Rating Upgraded by Zacks Investment Research
CIBT Education Group  Sets New 52-Week Low at $0.62
CIBT Education Group Sets New 52-Week Low at $0.62
Mercury Protocol 24-Hour Trading Volume Reaches $0.00
Mercury Protocol 24-Hour Trading Volume Reaches $0.00
Solarwindow Technologies  vs. Aemetis  Financial Survey
Solarwindow Technologies vs. Aemetis Financial Survey
Analyzing BIOQUAL  & Medpace
Analyzing BIOQUAL & Medpace
-$0.55 EPS Expected for ACADIA Pharmaceuticals Inc.  This Quarter
-$0.55 EPS Expected for ACADIA Pharmaceuticals Inc. This Quarter


Leave a Reply

 
© 2006-2019 Zolmax.